Skip to content

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02854982
Acronym
EPICAP-QALY
Enrollment
900
Registered
2016-08-04
Start date
2015-09-01
Completion date
2017-07-31
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostatic Neoplasms, Quality of Life

Brief summary

To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Interventions

PROCEDUREtherapeutic management of the prostate Cancer as usual

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
MALE
Age
No minimum to 75 Years
Healthy volunteers
Yes

Inclusion criteria

\- exposed group Inclusion Criteria: * prostate cancer diagnosed from 1 December 2011 to 31 December 2014 * under 75 and residing in the Hérault department at diagnosis * recruited in the EPICAP study

Exclusion criteria

* having relapsed in the range * non-exposed group: Inclusion Criteria: * controls (without prostate cancer) recruited in the EPICAP study * matched to cases on age (5 years) * residing in the Hérault department

Design outcomes

Primary

MeasureTime frame
EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)3 years from diagnosis for cases of prostate cancer and from recruitment for controls

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026